Skip to main content
. 2020 Feb 11;9(2):415. doi: 10.3390/cells9020415

Figure 1.

Figure 1

miRNAs involved as oncogenes and oncosuppressors targeting MAPK and PI3K/AKT pathways in melanoma resistant cells to BRAFi.